Treating prehypertension [1]

New England Journal of Medicine

Volumn 355, Issue 4, 2006, Pages 416-

  Grassi, Daniel G ^a  

^a UNIVERSIDAD AUSTRAL   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CANDESARTAN; ANGIOTENSIN RECEPTOR ANTAGONIST; BENZIMIDAZOLE DERIVATIVE; BIPHENYL DERIVATIVE; CANDESARTAN HEXETIL; TETRAZOLE DERIVATIVE;

CARDIOVASCULAR RISK; DOSE RESPONSE; DRUG EFFICACY; HUMAN; HYPERTENSION; LETTER; MORBIDITY; MORTALITY; PREDICTION; PRIORITY JOURNAL; QUESTIONNAIRE; CARDIOVASCULAR DISEASE; NOTE; RISK;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; BIPHENYL COMPOUNDS; CARDIOVASCULAR DISEASES; HUMANS; HYPERTENSION; RISK; TETRAZOLES;

EID: 33746445982     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc061382     Document Type: Letter

References (1)

1. Julius S, Nesbitt SD, Egan BM, et al. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med 2006;354:1685-97.